Zurueck zur Suche

Reporte zur Charge U015689

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

28Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 10 KS 8 MI 3 CO 3 MD 2 VA 2

VAERS 1829116

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

schwer
Staat
MD
Alter
15,0
Geschlecht
F
Eingang
29.10.2021
Impfdatum
29.10.2021
Beginn
29.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness

Symptomtext

Pt passed out for 30 seconds after receiving her vaccines. Cold compresses applied to pt?s head and neck. Pt drank some water. BP 100/63 P: 78 Temp: 96.8 99% on room air. Pt was monitored for 15 mins and then sent home

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None that were known
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
None
Vorherige Impfungen
-

VAERS 1950383

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

mild
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
22.02.2022
Impfdatum
07.12.2021
Beginn
10.12.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Otitis media Otitis media acute Pyrexia Rash Viral upper respiratory tract infection Wrong product administered

Symptomtext

My Medical Assistant accidentally gave MMRV plus Varicella instead of MMR plus varicella, resulting on extra dose of varicella vaccine Child started having high fevers up to 103 three days after immunizations. I saw baby in clinic and diagnosed with viral URI and bilateral acute otitis media, started on antibiotic (cefdinir), offered Covid 19 and flu testing which parents refused. Baby presented on 12/22/21 with widespread rash. Parents were concerned about varicella. Provider thinks maybe viral rash vs delayed reaction to antibiotic. Rash compeletly resolved

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
none, parents refused swabs
Aktuelle Erkrankungen
none prior
Vorgeschichte
none
Andere Medikamente
none
Allergien
peanuts
Vorherige Impfungen
-

VAERS 1950383

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

mild
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
22.02.2022
Impfdatum
07.12.2021
Beginn
10.12.2021
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Otitis media Otitis media acute Pyrexia Rash Viral upper respiratory tract infection Wrong product administered

Symptomtext

My Medical Assistant accidentally gave MMRV plus Varicella instead of MMR plus varicella, resulting on extra dose of varicella vaccine Child started having high fevers up to 103 three days after immunizations. I saw baby in clinic and diagnosed with viral URI and bilateral acute otitis media, started on antibiotic (cefdinir), offered Covid 19 and flu testing which parents refused. Baby presented on 12/22/21 with widespread rash. Parents were concerned about varicella. Provider thinks maybe viral rash vs delayed reaction to antibiotic. Rash compeletly resolved

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
none, parents refused swabs
Aktuelle Erkrankungen
none prior
Vorgeschichte
none
Andere Medikamente
none
Allergien
peanuts
Vorherige Impfungen
-

VAERS 1854628

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

mild
Staat
CO
Alter
10,0
Geschlecht
F
Eingang
09.11.2021
Impfdatum
09.11.2021
Beginn
09.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Fall Pallor

Symptomtext

3 minuets post vaccination of COVID vaccine and child got dizzy and fell out of chair and was pale. Child denied loosing consciousness. Placed child on mat, raised feet on chair, placed a cool cloth on forehead, given juice and snacks. Recovered within 10 minuets.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1846075

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

mild
Staat
MD
Alter
16,0
Geschlecht
M
Eingang
05.11.2021
Impfdatum
05.11.2021
Beginn
05.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Gait disturbance Hyperhidrosis Nausea Vomiting

Symptomtext

Patient stood up after receiving vaccinations, stated he felt weak and tripped. Caught by father, guided back to examination chair. Patient reported feeling nauseated and was visibly diaphoretic. RN called for assistance, instructed patient to lie down on his side. Emergency kit brought to patient. Cool compress given. Patient did not lose consciousness at anytime. One episode of emesis. Reported not eating breakfast or drinking anything prior to coming into clinic. Rested for 10 minutes in exam room, stated improvement in symptoms. Able to stand and walk out with no assistance needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
Vital signs taken at time of adverse reaction. Blood pressure 110/60, heart rate 70, respirations 18.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2426108

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
01.09.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event

Symptomtext

I have not noticed any adverse effects at this time; misread the label when pulling MMR out of the freezer, believed at the time of pulling the vaccine that MMR was in the freezer with VARIVAX, the vaccine in the freezer was actually Proquad; varivax and proquad administered the same day misread the label when pulling MMR out of the freezer, believed at the time of pulling the vaccine that MMR was in the freezer with VARIVAX, the vaccine in the freezer was actually Proquad; did not double checked the vial on the vaccine to make sure it was the right medication; This spontaneous report has been received from a registered nurse concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided. On 01-AUG-2022 at 13:45, the patient was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck)(VARIVAX) in the right arm for prophylaxis, lot #U015689, expiration date was not provided, however, upon internal validation was confirmed to be 18-MAY-2023 (strength, dose, frequency and route of administration were not provided). On the same date, the registered nurse administered in error a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneously in the left arm also for prophylaxis lot #U009261, expiration date was not provided, however, upon internal validation was confirmed to be 19-SEP-2022 (strength, dose and frequency were not reported) asat the time of pulling the vaccine out from the freezer he took the measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) instead of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (MMR-II) vaccine. The registered nurse reported that the patietn was scheduled to receive five vaccines which included hib vaccine conj (tet tox) (ACT-HIB), pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) and hepatitis a vaccine inact (HEP A IN VAC). On the same date, the registered nurse notified the vaccination error to the patient's mother, she inquired regarding the possible adverse effects that double vaccination with varicella vaccine, however, the patient's mother informed that the patient had no experienced any adverse effect from the vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
ACT-HIB; PREVNAR 13; HEP A IN VAC
Allergien
-
Vorherige Impfungen
-

VAERS 2408966

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
CO
Alter
1,0
Geschlecht
M
Eingang
11.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

On 08/01/2022 at approximately 01:45 PM, RN administered MMRV (Measles, Mumps, Rubella and Varicella) vaccine in error to pt. in left upper arm subcutaneously in the child clinic room. Pt. was scheduled to receive five vaccines today which included pediatric Hepatitis A (Hep A), Pneumococcal conjugate (PVC-13), Haemophilus Influenza type B (Hib), Measles, mumps, rubella (MMR), and Varicella (VAR-Varivax). RN misread the vaccination label when pulling MMR out of the freezer. RN believed at the time of pulling the vaccine, that MMR is in the freezer with VAR. The vaccine in the freezer was actually measles, mumps, rubella and varicella (MMRV-Proquad) Both MMRV and VAR were labeled as state vaccines. Which at the time, I believed the patient to be eligible. RN did not complete one of my six rights of administration by double checking the vial on the vaccine to make sure it was the right medication. I believe if I had completely turned the vaccine vial, I would have read the entire label. RN made a telephone call to parent at approximately 03:10 PM to notify her that her son received a double dose of the VAR which is a live vaccine, I relayed side effects of vaccines and what to watch out such as increase in fever, redness, soreness and pain at injection site and irritability. Parent asked RN "is my son going to come down with chicken pox later and possibly give it to my other son?", and RN replied, "he is not likely to come down with chicken pox and become contagious" Parent had no further question and she was given my name and the name of my immediate supervisor to call if she had additional questions. Parent did not notice any adverse effects of vaccine at this time but stated to the effect "I will keep an eye on him" At 05:02 RN made call to Merck, the vaccine manufacturer to get additional information on other adverse effects. RN spoke with Merck. Rep relayed that Merck showed no other adverse effects than those side effects listed for each vaccine as Fever, Irritability, redness, soreness or pain at the injection site, and that contracting chicken pox was not listed as an adverse event, side effect when the two vaccines MMRV (Proquad) and Var (Varivax) were given together. Rep at Merck is to provide information via email on findings with RN. At 05:21 PM, RN made additional call to parent on MERCK findings on adverse events, side effects when taking Proquad and Varivax together and that there were no findings to support that patients contracted chicken pox after vaccination. RN to email copy of findings from Merck to parent once received. RN asked parent how her son was doing now and she replied "he is resting now as he typically does after vaccination, I gave him pediatric Tylenol before resting, but I have not noticed any adverse effects at this time". She thanked me for the information and stated she would call if she had questions. On 8/2/2022 at 9:20 AM Information was sent to parent at the email provided from parent, she stated to the effect that this was an old work email she had kept and had been using and never changed it. Parent was given information provided in attachments from Merck. On 8/2/2022 at 3:46 PM, RN made a call to parent, I received her voice mail and a voice mail message was left by me asking parent is she had received my email with the information and to call if she had any questions, in addition RN asked parent on the well being of her son. On 8/3/2022 RN's supervisor made follow up telephone call to parent to inquire on well being of her son, There was no answer, a message was left for parent to return call. No call back known to be received and no return messages were left. Result of outcome of adverse event(s) is unknown due to no follow up response from Patient's parent.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
Unkown
Aktuelle Erkrankungen
Parent denies current illness, unkown up to one month prior.
Vorgeschichte
None reported by parent at time of vaccination.
Andere Medikamente
Unkown
Allergien
Parent denies allergies to medication or foods.
Vorherige Impfungen
-

VAERS 2286899

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
VA
Alter
11,0
Geschlecht
M
Eingang
20.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; two doses were administered after a temperature excursion that occurred on 4/29/2022.; This spontaneous report was received from a Licensed Practical Nurse, referring to a 11-year-old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 02-MAY-2022, the patient was vaccinated with improperly stored of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot # U022320, U026207, U028164, U015689 and U025791 has been verified to be a valid lot number varicella virus vaccine live (oka/merck), expiration date reported and establish as 15-JUL-2023, 24-AUG-2023, 09-SEP-2023, 18-MAY-2023 and 19-AUG-2023 respectively) (0.5 ml, strength, route of administration and anatomical location were not provided) (specific lot# was unspecified) (Product storage error). The temperature of storage and time frame of the excursion were 0.8 degree Celsius for 4 hours and 19 minutes respectively. There was no previous temperature excursion. No adverse event reported. Another patient was capture in Case# 2205USA004267. This is one of some reports from same reporter.; Sender's Comments: US-009507513-2205USA000806: US-009507513-2205USA004267:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2286898

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
VA
Alter
4,0
Geschlecht
M
Eingang
20.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE; two doses were administered after a temperature excursion that occurred on 4/29/2022.; This spontaneous report was received from a Licensed Practical Nurse, referring to a 4-year-old male patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 02-MAY-2022, the patient was vaccinated with improperly stored of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot # U022320, U026207, U028164, U015689 and U025791 has been verified to be a valid lot number varicella virus vaccine live (oka/merck), expiration date reported and establish as 15-JUL-2023, 24-AUG-2023, 09-SEP-2023, 18-MAY-2023 and 19-AUG-2023 respectively) (0.5 ml, strength, route of administration and anatomical location were not provided) (specific lot# was unspecified) (Product storage error). The temperature of storage and time frame of the excursion were 0.8 degree Celsius for 4 hours and 19 minutes respectively. There was no previous temperature excursion. No adverse event reported. Another patient was capture in Case# 2205USA004796. This is one of some reports from same reporter.; Sender's Comments: US-009507513-2205USA000806: US-009507513-2205USA004796:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277362

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
14.05.2022
Impfdatum
19.03.2022
Beginn
19.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered No adverse event Product storage error

Symptomtext

no additional AE information provided; VARIVAX that experienced a supported temperature excursion was administered to two patients on March 19, 2022; dose 5 mL; This spontaneous report was received from physician and refers to a patient of unknown age and gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported. On 19-MAR-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 5 mL for prophylaxis (lot #U015689, expiration date: 18-MAY-2023; strength and route were not reported) (incorrect dose administered). The vaccine had a temperature excursion at temperature -14 degree Celsius up to -10 degree Celsius (-14.5 degree Celsius) for 5 min (product storage error). No additional adverse event information was provided. This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-2204USA006498:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249225

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
23.04.2022
Impfdatum
19.03.2022
Beginn
19.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE information provided.; temperature excursion; This spontaneous report was received from a physician, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medication was not provided. On 19-MAR-2022, the patient was vaccinated with improper stored varicella virus vaccine live (oka/merck) (VARIVAX) (0.5 ml, lot #U015689, expiration date: 18-MAY-2023, strength, and route of administration were not provided) for prophylaxis. The vaccine administered experienced temperature excursions of -14 Degree Celsius to -10 Degree Celsius with average of -14.5 Degree Celsius for 5 minutes (product storage error). No additional adverse event information provided. This is one of two cases from same reporter.; Sender's Comments: US-009507513-2204USA006500:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1839574

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
03.11.2021
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AEs or PQC reported; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 25-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U015689, has been verified to be a valid lot number, expiration date was reported as 13-MAY-2023, but upon internal validation established as 18-MAY-2023, 0.5 milliliter, strength was not reported) subcutaneously (SQ) for prophylaxis. The vaccine administered after temperature excursion. Administered varicella virus vaccine live (oka/merck) (VARIVAX) were stored at 25.9 degrees Fahrenheit (F) for 1 hour and 30 minutes. There was no previous temperature excursion reported. No other adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1787459

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
15.10.2021
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product temperature excursion issue

Symptomtext

No other AEs or PQC reported; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided. On 25-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # U015689, expiration date 18-MAY-2023, 0.5 milliliter, subcutaneous) after temperature excursion for prophylaxis (product storage error). Temperature excursion was 25.9 Fahrenheit degree for 1 hour and 30 minutes. There was no previous temperature excursion. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product temperature excursion issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1787457

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
15.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No other AE or PQC reported; vaccine administered after temperature excursion.; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 01-OCT-2021, the patient was vaccinated with an improper stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U015689 and expiration date 18-MAY-2023, 0.5 milliliter for prophylaxis (strength, route, frequency and anatomical location were unknown). The administered dose of the vaccine was stored with a temperature of 25.9 degrees Fahrenheit, with a time frame of 1 hour and 30 minutes. There was no previous temperature excursion. No adverse event reported (product storage error and no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1787455

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
15.10.2021
Impfdatum
27.09.2021
Beginn
27.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medication, and previous drug reactions or allergies. On 27-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (SQ), at a dose of 0.5 milliliter (ml) (lot number U015689, which was verified to be a valid lot number, expiration date reported as 13-MAY-2023 but upon internal validation established as 18-MAY-2023), as prophylaxis (frequency, route of administration, anatomical location and vaccination scheme were not reported). The vaccine was administered after a temperature excursion of 25.9 F during a time frame of 1 hour and 30 minutes (product storage error). There was not a previous temperature excursion. No adverse events were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2110USA000932: US-009507513-2110USA001023:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1787452

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
15.10.2021
Impfdatum
24.09.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

vaccine administered after temperature excursion.; No adverse event; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 24-SEP-2021, the patient was vaccinated with an improper stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U015689 and expiration date 18-MAY-2023, 0.5 milliliter for prophylaxis (strength, route, frequency and anatomical location were unknown). The administered dose of the vaccine was stored with a temperature of 25.9 degrees Fahrenheit, with a time frame of 1 hour and 30 minutes. There was no previous temperature excursion. No adverse event reported (product storage error and no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1784980

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
MI
Alter
7,0
Geschlecht
F
Eingang
14.10.2021
Impfdatum
29.09.2021
Beginn
29.09.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Product administered to patient of inappropriate age

Symptomtext

The client was administered Dtap instead of Tdap, as she was 7 years old. She was given an extra dose of IPV, and an extra dose of MMR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1770330

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
08.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AEs or PQC reported; administered after temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of an unspecified age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not provided. On 01-OCT-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # U015689, expiration date was reported as 13-MAY-2023, however upon internal validation, it was established as 18-MAY-2023, 0.5 ml, subcutaneously (sq) for prophylaxis (strength was not provided). It was stated, that the vaccine before administration was stored at the temperature of 25.9 Fahrenheit degree (F) for 1 hour and 30 minutes (improper storage of product in use). No previous temperature excursion was detected. It was not specified, if the data logger was involved. No other adverse events (AEs) or product quality complaint (PQC) were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1770325

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
08.10.2021
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AEs reported; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 25-SEP-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, subcutaneous, lot number U015689, expiration date reported as 13-MAY-2023 but upon internal validation was determined as 18-MAY-2021 for prophylaxis. No adverse event was reported. The vaccine underwent a temperature excursion of 25.9 degrees Farhrenheit for 1 hour and 30 minutes. No previous temperature excursions were detected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1767720

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
07.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; Caller reports vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies and drug reactions/allergies were not reported. On 01-OCT-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (0.5 mL, lot # U015689 has been verified to be a valid lot number, expiration date was reported as 13-MAY-2023, but upon internal validation it was established as 18-MAY-2023; strength not reported), administered subcutaneously for prophylaxis. It was reported that the vaccine had a temperature excursion and was exposed to 25.9 Fahrenheit for 1 hour and 30 minutes (product storage error), but there was no pervious temperature excursion. No other adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751675

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
28.09.2021
Beginn
28.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 28-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751674

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
27.09.2021
Beginn
27.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 27-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751673

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
24.09.2021
Beginn
24.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 24-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751672

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
23.09.2021
Beginn
23.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 23-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751671

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
23.09.2021
Beginn
23.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 23-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751670

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
23.09.2021
Beginn
23.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 23-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751669

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
22.09.2021
Beginn
22.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 22-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007144:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1751668

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U015689

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.10.2021
Impfdatum
21.09.2021
Beginn
21.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional adverse event reported; lots: U015689 and U010395 have been administered to patients since the excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 21-SEP-2021, the patient was inadvertently administered with an improperly stored dose (product storage error) of varicella virus vaccine live (oka/merck)(VARIVAX) 1 dose for prophylaxis (strength, route of administration, and anatomical location were not reported; lot number U015689 had been verified to be a valid number; expiration date 18-MAY-2023). The temperature excursion was at -12.0 degree Celsius (C), for a time frame of 1 hour and 50 minutes. No had previous temperature excursion. No additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2109USA007192: US-009507513-2109USA007193: US-009507513-2109USA007194: US-009507513-2109USA007195: US-009507513-2109USA007196: US-009507513-2109USA007197: US-009507513-2109USA007198: US-009507513-2109USA007199:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-